TCG and the Medical Technology Industry

Medical technology has never held more potential to create new products that can positively impact clinical outcomes, while lowering overall healthcare costs.  At the same time, changing regulatory and reimbursement environments may lead to higher costs of clinical development as well as increase the pressure to reduce costs.  This means that companies have to rethink many of the traditional approaches for delivering sales and profit growth.  At the same time, companies with innovative medical technologies may find that partnering with larger companies … or businesses with established sales channels … can lead to earlier and more profitable revenues.

Whatever technology you have developed, TCG partners will work collaboratively to develop strategies that capitalize on your innovations while also meeting needs of the customer, at pricing that is consistent with commercial success.

To read sample Case Studies summarizing the success of our international clients, see below:

• Product Development and Commercial Pathway for an Early Stage Diagnostics Company
• Opportunity Assessment and US Market Entry Plan for a New Dental Device
• Acquisition Strategy for a Global Specialty Chemicals and Materials Company
• Commercial Launch of an Innovative Research Service Business
• Creating Value from a Life Sciences Technology Platform
• Entering a New Market Via Partnering
• Veterinary Market Strategy
• US Commercialization Strategy for an Innovative Wound Care Product

When partnering with European companies, you must be aware of the cultural differences. An interview with Dr. Bob. Keefer, originally published in the Triangle Tech Journal, gives valuable hints.

"Commercialization is all part of brand management, how you build a brand. The companies who specialize in this may prove very helpful" says Dr. Robert Keefer. Read "Companies Supporting Other Companies" from The State of Life Sciences in North Carolina (Supplement) in The Scientist.